| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000010133 |
| Receipt No. | R000011869 |
| Official scientific title of the study | Randomized study of endobronchial ultrasound-guided transbronchial biopsy (EBUS-TBB) with virtual bronchoscopic navigation (VBN) for the diagnosis of small peripheral pulmonary lesions: TBB with 3.0-mm ultrathin bronchoscope vs. TBB followed by transbronchial needle aspiration (TBNA) with 4.0-mm bronchoscope |
| Date of disclosure of the study information | 2013/02/28 |
| Last modified on | 2018/09/03 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Randomized study of endobronchial ultrasound-guided transbronchial biopsy (EBUS-TBB) with virtual bronchoscopic navigation (VBN) for the diagnosis of small peripheral pulmonary lesions: TBB with 3.0-mm ultrathin bronchoscope vs. TBB followed by transbronchial needle aspiration (TBNA) with 4.0-mm bronchoscope | |
| Title of the study (Brief title) | Randomized study of EBUS-TBB-VBN with 3.0-mm bronchoscope vs. EBUS-TBB/TBNA-VBN with 4.0-mm bronchoscope | |
| Region |
|
|
| Condition | ||
| Condition | Benign or malignant pulmonary lesions | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the diagnostic yield of EBUS-TBB-VBN using 3.0-mm ultrathin bronchoscope and EBUS-TBB/TBNA-VBN using 4.0-mm bronchoscope for the diagnosis of small peripheral pulmonary lesions |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase III |
| Assessment | |
| Primary outcomes | 1. Diagnostic yield |
| Key secondary outcomes | 1. Diagnostic yield on histology specimens
2. Diagnostic yield: benign or malignant 3. Diagnostic yield according to lesion size: 20 mm> or 20 mm< 4. Diagnostic yield according to location 5. Visibility by EBUS 6. Diagnostic yield according to location of probe in relation to target lesion 7. Diagnostic yield according to procedures (TBB, TBNA, washing) 8. Level of bronchus reached 9. Level of bronchus imaged by VBN system 10. Direct visibility of lesions with bronchoscope 11. Time for examination procedure 12. Incidence of adverse effects |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | YES |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | EBUS-TBB-VBN using 3.0-mm ultrathin bronchoscope | |
| Interventions/Control_2 | EBUS-TBB/TBNA-VBN using 4.0-mm bronchoscope | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Patients with peripheral pulmonary lesion 30 mm<= in size requiring diagnostic bronchoscopy
2. 20 years old or more 3. Informed consent |
|||
| Key exclusion criteria | 1. Case with serious concomitant medical illness
2. Central pulmonary lesions 3. Diffuse pulmonary lesions 4. Prior failure in this trial 5. Case with pure ground glass opacity 6. Patients requiring other bronchoscopic procedures (e.g. EBUS-TBNA, BAL) 7. Bleeding tendency 8. Pregnant woman 9. Other presumed difficulties for patients in this trial |
|||
| Target sample size | 360 | |||
| Research contact person | |
| Name of lead principal investigator | Hideo Saka |
| Organization | Nagoya Medical Center |
| Division name | Department of Respiratory Medicine |
| Address | 4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan |
| TEL | 052-951-1111 |
| Public contact | |
| Name of contact person | Masahide Oki |
| Organization | Nagoya Medical Center |
| Division name | Department of Respiratory Medicine |
| Address | 4-1-1 Sannomaru, Naka-ku, Nagoya 460-0001, Japan |
| TEL | 052-951-1111 |
| Homepage URL | |
| masahideo@gmail.com | |
| Sponsor | |
| Institute | Nagoya Medical Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 国立病院機構名古屋医療センター (愛知県)
岐阜総合医療センター (岐阜県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000011869 |